Symbol="ACRX"
AssetType="Common Stock"
Name="AcelRx Pharmaceuticals Inc"
Description="AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. The company is headquartered in Redwood City, California."
CIK="1427925"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="351 GALVESTON DRIVE, REDWOOD CITY, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="11907500"
EBITDA="-30424000"
PERatio="0.175"
PEGRatio="0"
BookValue="1.304"
DividendPerShare="0"
DividendYield="0"
EPS="6.24"
RevenuePerShareTTM="0.214"
ProfitMargin="24.2"
OperatingMarginTTM="-18.11"
ReturnOnAssetsTTM="-0.408"
ReturnOnEquityTTM="0"
RevenueTTM="1771000"
GrossProfitTTM="-5030000"
DilutedEPSTTM="6.24"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="125"
AnalystTargetPrice="4"
TrailingPE="0.175"
ForwardPE="1.06"
PriceToSalesRatioTTM="11.8"
PriceToBookRatio="0.69"
EVToRevenue="10.28"
EVToEBITDA="0.309"
Beta="0.192"
num_52WeekHigh="7.6"
num_52WeekLow="0.55"
num_50DayMovingAverage="0.926"
num_200DayMovingAverage="1.932"
SharesOutstanding="10924300"
DividendDate="None"
ExDividendDate="None"
symbol="ACRX"
open="1.17"
high="1.17"
low="1.09"
price="1.15"
volume="69521.00"
latest_trading_day="2023-07-05"
previous_close="1.09"
change="0.06"
change_percent="5.5046%"
aroon_positive_momentum_days="22"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="22"
Volume_recent_avg="185485"
Change_recent_avg="-0.01"
Delta_recent_avg="0.1"
Variance_recent_avg="0.05"
Change_ratio_recent_avg="-1.22"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="22"
Aroon_momentum_negative="78"
image_negative_thumbnail_id_1="125"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0051.jpeg"
image_negative_thumbnail_id_2="113"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0063.jpeg"
image_neutral_thumbnail_id_1="565"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0034.jpeg"
image_neutral_thumbnail_id_2="531"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0068.jpeg"
image_positive_thumbnail_id_1="1009"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0171.jpeg"
image_positive_thumbnail_id_2="609"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0099.jpeg"
image_professor_thumbnail_id_1="1169"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0003.jpeg"
image_professor_thumbnail_id_2="1199"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0033.jpeg"
